The Multidimensional Relationship Between Diagnostic Tools And Mental Health Stigma
Stigma is one of the leading challenges in mental health, posing a significant barrier to timely access to treatment, leading to higher mortality rates and reduced quality of life. Goffman’s (1963) classic definition of
लेखक Yashee Jha··21K पढ़े गए
The Multidimensional Relationship Between Diagnostic Tools And Mental Health Stigma
Stigma is one of the leading challenges in mental health, posing a significant barrier to timely access to treatment, leading to higher mortality rates and reduced quality of life. Goffman’s (1963) classic definition of stigma as “an attribute that is deeply discrediting”, reducing “a whole and usual person to a tainted, discounted one”, is foundational but incomplete.
Link and Phelan (2001) provide a more comprehensive conceptualisation of stigma as a convergence of five components: labelling, stereotyping, separation, status loss and discrimination achieved through power asymmetry. Although formal diagnoses demystify suffering and facilitate alleviation, the classificatory power of diagnostic frameworks becomes a key site through which stigma is formally proliferated. Evoking empirical evidence, this article evaluates the relationship between four prominent contemporary diagnostic frameworks and mental health stigma.
The relationship between diagnostic frameworks and stigma is dynamically produced across contexts, resisting overly simplified linear or unidirectional causal interpretations. For instance, Rosenhan’s classic 1973 study, “On Being Sane in Insane Places”, demonstrated how a mere false diagnostic label of being “Schizophrenic” led clinicians to misinterpret and pathologise ordinary, non-symptomatic behaviour, showcasing that diagnosis actively produces stigma by shaping perception and treatment independent of lived reality.
Conversely, anticipated stigma and self-stigma often precede formal diagnosis, discouraging help-seeking behaviour and showcasing a negative correlational relationship. These contrasting trajectories underscore the dialectical and recursive nature of the relationship between diagnosis and stigma, which unfolds through shifting, reciprocal processes that vary across time, institutions, culture and lived experience.
In collectivistic societies, stigma is more deeply internalised and moralised, positioning mental illness in a more negative social light than in their individualistic counterparts. Across 27 countries, Thornicroft et al. (2009) found that 72% of individuals diagnosed with schizophrenia felt compelled to conceal their diagnosis, while 47% reported discrimination in forming friendships and 64% experienced discrimination when applying for employment, training or education, highlighting how stigma discourages disclosure and engagement within formal diagnostic systems. Nonetheless, attempting to reduce stigma with insufficient understanding of the diagnostic processes themselves has been linked to patterns of overdiagnosis, particularly ADHD, Autism Spectrum Disorder and other common mental disorders.
The Diagnostic and Statistical Manual of Mental Disorders (DSM), developed by the American Psychological Association (APA), is the most dominantly used diagnostic tool in contemporary psychiatry. However, its symptom-count and heavy categorical approach have been criticised for lowering the diagnostic horizon, grossly inflating prevalence estimates up to 46.4%. Further, it has also been criticised for limited construct validity, as high comorbidity rates of up to 50% suggest that stigma is reinforced not only through diagnostic labels but also through poor empirical separability.
DSM-based diagnosis has led to a greater attribution of mental illness to neurobiological explanations, increasing support for treatment but failing to reduce stigma among the masses. Moreover, while biomedical framing has somewhat reduced the moral blame placed on the mentally ill, the perception of “dangerousness” and increased desire for social distance from those diagnosed have snowballed, revealing the ambivalent nature of the relationship between diagnostic frameworks and stigma.
At the clinical level, mental health professionals may themselves be catalysing agents in the reproduction of stigma. Individuals diagnosed with personality disorders were perceived as less deserving of treatment and resources, deemed more difficult to manage, and had their suicide attempts dismissed as attention-seeking and annoying. The relationship between diagnostic frameworks and stigma is further complicated by gendered effects, particularly in the classification of women’s distress.
Epidemiological data suggest a significant narrowing of gender differences in “Major Depressive Disorder” alongside shifts in women’s social roles, pathologising women’s emotional responses to structural inequality, relational strain and care burdens. The DSM’s label-intensive diagnosis is rated to be the most stigmatising among clinicians.
The International Classification of Diseases (ICD) attempts to recalibrate diagnostic practice by adopting a spectrum-based, severity-focused approach to personality disorders, in contrast to the DSM’s categorically restrictive framework, aiming to reduce stigma from fixed labels. The latest version, the ICD-11, includes 19 disorders not included in the DSM-5 and has a diagnostic accuracy of 71.9%, making it a preference for clinical utility. Also, the ICD’s multilingual applicability contributes to its global operability, integrating it seamlessly into policy-level decision-making.
However, the absence of clearly defined severity thresholds and the lack of validated diagnostic instruments risk reproducing overdiagnosis and reliance on clinical judgement rather than validated psychometric thresholds. For instance, in a sample of Chinese earthquake survivors, the ICD-11 yielded a higher prevalence estimate of 18.6% for Post-Traumatic Stress Disorder (PTSD), compared to 15.9% for the DSM-5.
Moreover, in stark contrast to the DSM, the biggest limitation of the ICD is that it does not account for comorbidity, particularly with respect to neurodevelopmental disorders such as Autism Spectrum Disorder (ASD) or Fetal Alcohol Spectrum Disorder (FASD), which can overlap symptomatically with personality disorders, thereby worsening the exceedingly high, pre-existing stigma against personality disorders. Hence, the ICD reflects a reformist-reproductive relationship with stigma, wherein it reforms rather than restructures the classificatory system of the DSM, yet continues to reproduce stigma through diagnostic inflation.
Extending the ICD’s spectrum approach, the Research Domain Criteria, or RDoC, strives to reduce stigma through its dimensionality by blurring the divisive binary between mentally “healthy” and “ill”. By framing mental illnesses as an extreme of normality, the sense of otherness attached to psychiatric disorders may be lessened. However, such an approach may unintentionally and paradoxically trivialise more serious mental conditions, reinforcing blame-based stigma.
Even when diagnostic labelling practices move away from categorical classification to multidimensional frameworks that explicitly reject traditional diagnostic categories, stigma does not disappear. Instead, the type of disorder becomes the determining variable, revealing the “what” facet of the relationship between diagnostic frameworks and stigma, with Schizophrenia and Antisocial Personality Disorder (ASPD) at the bottom of the hierarchy.
The RDoC’s continuum belief, which frames mental illness as a spectrum of variation rather than pathological deviation, has been shown to foster greater identification with those experiencing mental distress. Yet, this effect is uneven: while 42–58% of respondents endorsed empathy for those with depression, only around one-third did so for schizophrenia or alcohol use disorder, whereas support for ADHD exceeded opposition by more than sixfold.
These results illustrate how the relationship between diagnosis and stigma operates disproportionately and hierarchically. While the DSM produces stigma through identity labels, the RDoC does so through minimisation of suffering and exaggeration of normalcy. Furthermore, it seems to enforce a top-down approach by over-fragmenting brain constructions into granular sub-systems, much in contrast to a bottom-up approach of aetiological explanations for psychopathologies. This points to a displacement relationship between diagnostic frameworks and stigma, in which stigmatising effects are not eliminated but relocated from categorical labelling to epistemic framing.
Another upcoming and frequently used contemporary framework is the Hierarchical Taxonomy of Psychopathology (HiTOP), which overcomes the limitations of the DSM, ICD-11 and the RDoC by employing a dimensional as well as hierarchical approach.
One of the strengths of HiTOP is that it addresses within-disorder heterogeneity by clustering related symptoms together and assigning unrelated symptoms to other causes, without dismissing them altogether. In doing so, it accounts for comorbidity predictability, improving on this loophole of the ICD-11 and RDoC, thereby reducing stigma from overlapping layers of diagnosis. Among healthcare providers, HiTOP is rated to be the least stigmatising.
Although HiTOP offers conceptual advantages over the DSM and ICD-11, critics argue that, due to a lack of substantive empirical evidence, it is premature for use in real-world clinical settings and does not effectively demonstrate superiority over traditional nosologies (a branch of medical science that deals with the systematic classification, description and naming of diseases).
Another challenge lies in HiTOP’s difficulty in integrating its dimensional constructs into healthcare, legal, administrative and insurance systems that continue to rely on explicit diagnostic categories for eligibility, accountability and resource allocation. The relationship between the HiTOP framework and stigma can be described as latent, as it offers strong theoretical promise for stigma reduction but remains empirically under-validated and non-embedded in routine diagnostic practice.
Taken together, the relationship between diagnostic frameworks and mental health stigma is dynamic, contextually mediated and framework-specific. The DSM reflects an ambivalent relationship, where biomedical conceptualisations facilitate heightened perceptions of dangerousness, identity fixation and gendered pathologisation. The ICD-11 illustrates a reformist-reproductive relationship, attempting to mitigate stigma through dimensional severity while continuing to reproduce it via diagnostic inflation and weak comorbidity recognition.
The RDoC reveals a displacement relationship, shifting stigma away from diagnostic labels towards epistemic minimisation, with stigma persisting differentially across disorder types. Finally, HiTOP illustrates a latent relationship with stigma: despite strong theoretical promise in addressing heterogeneity and comorbidity, its limited empirical validation and institutional non-integration constrain its capacity to meaningfully disrupt stigma in practice. Collectively, the persistence of stigma across diagnostic frameworks suggests a need for optimisation in the way psychological distress is understood, operationalised and embedded within social institutions.